RSCM
GBT
Rock Springs Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-288,279
| Closed | -$18.2M | – | 160 |
|
2020
Q2 | $18.2M | Buy |
288,279
+8,279
| +3% | +$523K | 0.5% | 69 |
|
2020
Q1 | $14.3M | Buy |
280,000
+15,000
| +6% | +$766K | 0.59% | 57 |
|
2019
Q4 | $21.1M | Hold |
265,000
| – | – | 0.67% | 60 |
|
2019
Q3 | $12.9M | Hold |
265,000
| – | – | 0.51% | 63 |
|
2019
Q2 | $13.9M | Buy |
265,000
+20,000
| +8% | +$1.05M | 0.5% | 66 |
|
2019
Q1 | $13M | Hold |
245,000
| – | – | 0.5% | 66 |
|
2018
Q4 | $10.1M | Buy |
245,000
+95,000
| +63% | +$3.9M | 0.47% | 68 |
|
2018
Q3 | $5.7M | Hold |
150,000
| – | – | 0.21% | 111 |
|
2018
Q2 | $6.78M | Hold |
150,000
| – | – | 0.26% | 105 |
|
2018
Q1 | $7.25M | Hold |
150,000
| – | – | 0.31% | 96 |
|
2017
Q4 | $5.9M | Hold |
150,000
| – | – | 0.27% | 101 |
|
2017
Q3 | $4.66M | Hold |
150,000
| – | – | 0.21% | 105 |
|
2017
Q2 | $4.1M | Hold |
150,000
| – | – | 0.21% | 103 |
|
2017
Q1 | $5.53M | Buy |
150,000
+53,500
| +55% | +$1.97M | 0.32% | 86 |
|
2016
Q4 | $1.39M | Sell |
96,500
-1,500
| -2% | -$21.7K | 0.09% | 118 |
|
2016
Q3 | $2.26M | Hold |
98,000
| – | – | 0.14% | 118 |
|
2016
Q2 | $1.63M | Buy |
98,000
+20,000
| +26% | +$332K | 0.12% | 119 |
|
2016
Q1 | $1.24M | Buy |
78,000
+7,500
| +11% | +$119K | 0.1% | 121 |
|
2015
Q4 | $2.28M | Buy |
70,500
+10,500
| +18% | +$339K | 0.17% | 107 |
|
2015
Q3 | $2.53M | Buy |
+60,000
| New | +$2.53M | 0.21% | 106 |
|